KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Invested Capital (2016 - 2026)

Bausch Health Companies' Invested Capital history spans 18 years, with the latest figure at $18.7 billion for Q1 2026.

  • On a quarterly basis, Invested Capital fell 12.06% to $18.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $18.7 billion, a 12.06% decrease, with the full-year FY2025 number at $21.2 billion, up 4.21% from a year prior.
  • Invested Capital hit $18.7 billion in Q1 2026 for Bausch Health Companies, down from $21.2 billion in the prior quarter.
  • Over the last five years, Invested Capital for BHC hit a ceiling of $23.0 billion in Q1 2022 and a floor of $18.7 billion in Q1 2026.
  • Historically, Invested Capital has averaged $21.4 billion across 5 years, with a median of $21.4 billion in 2025.
  • Biggest five-year swings in Invested Capital: increased 6.09% in 2023 and later dropped 12.06% in 2026.
  • Tracing BHC's Invested Capital over 5 years: stood at $21.0 billion in 2022, then increased by 6.09% to $22.3 billion in 2023, then dropped by 8.83% to $20.3 billion in 2024, then grew by 4.21% to $21.2 billion in 2025, then fell by 11.74% to $18.7 billion in 2026.
  • Business Quant data shows Invested Capital for BHC at $18.7 billion in Q1 2026, $21.2 billion in Q4 2025, and $21.4 billion in Q3 2025.